| Strains | Features | References |
| Escherichia coli | | | ATCC8739 and ATCC10536 | Reference strains | | AG100 | Wild-type E. coli K-12 | [31] | AG100A | AG100 ΔacrAB::KANR | [31, 34] | AG100ATET | ΔacrAB mutant AG100, owing acrF gene markedly overexpressed; TETR | [31] | AG102 | ΔacrAB mutant AG100 | [35] | MC4100 | Wild type E. coli | | W3110 | Wild type E. coli | [36] | Enterobacter aerogenes | | | ATCC13048 | Reference strains | | EA-CM64 | CHLR resistant variant obtained from ATCC13048 over-expressing the AcrAB pump | [37] | EA3 | Clinical MDR isolate; CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR | [38] | EA27 | Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR and AMPR and NALR and STRR and TETR | [38, 39] | EA289 | KAN sensitive derivative of EA27 | [40] | EA298 | EA 289 tolC::KANR | [40] | EA294 | EA 289 ΔacrAB: ::KANR | [40] | Enterobacter cloacae | | | ECCI69 | Clinical isolates | Laboratory collection of UMR-MD1, University of Marseille, France | BM47 | Clinical isolates | Laboratory collection of UMR-MD1, University of Marseille, France | BM67 | Clinical isolates | Laboratory collection of UMR-MD1, University of Marseille, France | Klebsiella pneumoniae | | | ATCC12296 | Reference strains | | KP55 | Clinical MDR isolate, TETR, AMPR, ATMR, and CEFR | [41] | KP63 | Clinical MDR isolate, TETR, CHLR, AMPR, and ATMR | [41] | K24 | AcrAB-TolC | Laboratory collection of UMR-MD1, University of Marseille, France | K2 | AcrAB-TolC | Laboratory collection of UMR-MD1, University of Marseille, France | Providencia stuartii | | | NEA16 | Clinical MDR isolate, AcrAB-TolC | | ATCC29914 | Clinical MDR isolate, AcrAB-TolC | [42] | PS2636 | Clinical MDR isolate, AcrAB-TolC | | PS299645 | Clinical MDR isolate, AcrAB-TolC | | Pseudemonas aeruginosa | | | PA 01 | Reference strains | | PA 124 | MDR clinical isolate | [43] |
|
|
aAMP, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR, STRR, and TETR. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin, moxalactam, streptomycin, and tetracycline; MDR: multidrug resistant.
|